5th Circ. Upholds Drug Negotiations In Blow To Big Pharma
By Jeff Overley · August 27, 2026, 12:00 AM EDT
Medicare's landmark program of drug price negotiations doesn't flout constitutional provisions involving the separation of powers, due process or excessive fines, the Fifth Circuit ruled late Wednesday, delivering a fresh blow...
To view the full article, register now.